ENST00000699074.1:c.550-4574C>A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000699074.1(CMPK1):c.550-4574C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.43   (  14023   hom.,  cov: 20) 
Consequence
 CMPK1
ENST00000699074.1 intron
ENST00000699074.1 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -1.25  
Publications
3 publications found 
Genes affected
 CMPK1  (HGNC:18170):  (cytidine/uridine monophosphate kinase 1) This gene encodes one of the enzymes required for cellular nucleic acid biosynthesis. This enzyme catalyzes the transfer of a phosphate group from ATP to CMP, UMP, or dCMP, to form the corresponding diphosphate nucleotide. Alternate splicing results in both coding and non-coding transcript variants. [provided by RefSeq, Feb 2012] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83). 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.5  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| LINC01389 | NR_126355.1  | n.405-3351G>T | intron_variant | Intron 3 of 4 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| CMPK1 | ENST00000699074.1  | c.550-4574C>A | intron_variant | Intron 5 of 5 | ENSP00000514113.1 | |||||
| LINC01389 | ENST00000420876.1  | n.159-3351G>T | intron_variant | Intron 1 of 2 | 3 | |||||
| LINC01389 | ENST00000828805.1  | n.208-8564G>T | intron_variant | Intron 1 of 1 | 
Frequencies
GnomAD3 genomes   AF:  0.429  AC: 58163AN: 135432Hom.:  14023  Cov.: 20 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
58163
AN: 
135432
Hom.: 
Cov.: 
20
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome   AF:  0.429  AC: 58153AN: 135496Hom.:  14023  Cov.: 20 AF XY:  0.429  AC XY: 27711AN XY: 64530 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
58153
AN: 
135496
Hom.: 
Cov.: 
20
 AF XY: 
AC XY: 
27711
AN XY: 
64530
show subpopulations 
African (AFR) 
 AF: 
AC: 
9021
AN: 
35498
American (AMR) 
 AF: 
AC: 
5282
AN: 
12382
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2047
AN: 
3384
East Asian (EAS) 
 AF: 
AC: 
899
AN: 
4244
South Asian (SAS) 
 AF: 
AC: 
1877
AN: 
4186
European-Finnish (FIN) 
 AF: 
AC: 
4639
AN: 
7490
Middle Eastern (MID) 
 AF: 
AC: 
136
AN: 
276
European-Non Finnish (NFE) 
 AF: 
AC: 
32943
AN: 
65270
Other (OTH) 
 AF: 
AC: 
872
AN: 
1888
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.575 
Heterozygous variant carriers
 0 
 1194 
 2388 
 3583 
 4777 
 5971 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 550 
 1100 
 1650 
 2200 
 2750 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
970
AN: 
3298
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.